| Medical Mutual | Oncology Value: Opdivo® (nivolumab) (Intravenous) (EOV) | 2026-08-04 |
| Medical Mutual | Oncology Value: Padcev® (enfortumab vedotin-ejfv) (Intravenous) | 2026-08-04 |
| Medical Mutual | Enhanced Oncology Value: Rybrevant® (amivantamab-vmjw) (Intravenous) (EOV) | 2026-08-04 |
| Medical Mutual | Value: Sarclisa® (isatuximab-irfc) (Intravenous) | 2026-08-04 |
| Medical Mutual | Enhanced Oncology Value: Synagis® (Palivizumab) (Intramuscular) (EOV) | 2026-08-04 |
| Medical Mutual | Oncology Value: Tecelra® (afamitresgene autoleucel) (Intravenous) | 2026-08-04 |
| Medical Mutual | Enhanced Oncology Value: Tevimbra® (tislelizumab-jsgr) (Intravenous) (EOV) | 2026-08-04 |
| Medical Mutual | Enhanced Oncology Value: Trastuzumab: (Intravenous/Intrathecal/Intraventricular) (EOV) | 2026-08-04 |
| Medical Mutual | Enhanced Oncology Value: Trodelvy® (sacituzumab govitecan-hziy) (Intravenous) (EOV) | 2026-08-04 |
| Medical Mutual | Oncology Value: Vectibix® (panitumumab) (Intravenous) (EOV) | 2026-08-04 |